BioCentury
ARTICLE | Company News

Roche names Sanford-Burnham's Reed head of pRED division

January 16, 2013 2:28 AM UTC

Roche (SIX:ROG; OTCQX:RHHBY) named John Reed as head of its Pharma Research and Early Development (pRED) division, effective April 2. Reed, who will be located in Basel, Switzerland, was CEO at Sanford-Burnham Medical Research Institute (La Jolla, Calif.). He will replace Mike Burgess, who has served as interim head of pRED since Roche closed its R&D site in Nutley, N.J., last year as part of a restructuring of the division. The pharma said Burgess will leave Roche (see BioCentury, July 16, 2012). ...